Monkeypox: Information and Our Solutions
Monkeypox: Information and Our Solutions
Monkeypox: Information and Our Solutions
According to the Center for Disease Control and Prevention, Monkeypox is a rare disease that is caused by infection with monkeypox virus. Monkeypox virus belongs to the Orthopoxvirus genus in the family Poxviridae. Monkeypox was first discovered in 1958 when two outbreaks of a pox-like disease occurred in colonies of monkeys kept for research, hence the name ‘monkeypox.’ In humans, the symptoms of monkeypox are similar to but milder than the symptoms of smallpox. Monkeypox begins with fever, headache, muscle aches, and exhaustion. The main difference between symptoms of smallpox and monkeypox is that monkeypox causes lymph nodes to swell (lymphadenopathy) while smallpox does not. The incubation period (time from infection to symptoms) for monkeypox is usually 7−14 days but can range from 5−21 days (Centers for Disease Control and Prevention, 2022).
WHAT IS LIST Q?
When rare or novel viruses cause outbreaks of disease, there may be few if any disinfectants that have been tested and registered for use against that specific pathogen. To respond to situations like this, the EPA created “Emerging Viral Pathogen” guidance, which allows industry to submit data to the EPA to demonstrate a product’s efficacy against difficult to inactivate viruses. EPA’s List Q is a compilation of the products that have shown effectiveness against difficult to inactivate viruses and includes products for use against monkeypox.
MONKEYPOX GUIDANCE
State offers products on the EPA List Q that have demonstrated effectiveness against viruses similar to Monkeypox on hard, non-porous surfaces. Therefore, they can be used against Monkeypox when used in accordance with their respective directions for use on hard, non-porous surfaces. Please refer to the CDC at https://www.cdc.gov/poxvirus/monkeypox/index.html for more information.
STATE PRODUCTS ON LIST Q : DISINFECTANTS
Disinfectants for Emerging Viral Pathogens (EVPs): List Q
Quick Defense™ NDC™ (EPA Registration 1839-236-70799) has demonstrated effectiveness against viruses similar to Monkeypox on hard, non-porous surfaces. Therefore, Quick Defense™ NDC™ can be used against Monkeypox when used in accordance with the directions for use against rotavirus on hard, non-porous surfaces. Please refer to the CDC at https://www.cdc.gov/poxvirus/monkeypox/index.html for more information.
Triple Quick Fresh™ (EPA Registration #1839-83-70799) has demonstrated effectiveness against viruses similar to Monkeypox on hard, non-porous surfaces. Therefore, Triple Quick can be used against Monkeypox when used in accordance with the directions for use against human rotavirus on hard, non-porous surfaces. Please refer to the CDC at https://www.cdc.gov/poxvirus/monkeypox/index.html for more information.
Ecolution Disinfectant® (EPA Registration #61178-1-70799) has demonstrated effectiveness against viruses similar to Monkeypox on hard, non-porous surfaces. Therefore, Ecolution Disinfectant® can be used against Monkeypox when used in accordance with the directions for use against Rotavirus on hard, non-porous surfaces. Please refer to the CDC at https://www.cdc.gov/poxvirus/monkeypox/index.html for more information.
7 in One (EPA Reg. No. 6836-140-70799) has demonstrated effectiveness against viruses similar to Monkeypox on hard, non-porous surfaces. Therefore, 7 in One can be used against Monkeypox when used in accordance with the directions for use against rotavirus on hard, non-porous surfaces. Please refer to the CDC at https://www.cdc.gov/poxvirus/monkeypox/index.html for more information.
HAND CARE
The CDC always recommends practicing good hand hygiene, and specifically recommends hand hygiene after contact with an infected person or animal. Prevention | Monkeypox | Poxvirus | CDC. Some products to assist with hand hygiene include -
GENTLE FRESH™ FOAMING ALCOHOL SANITIZER
GENTLE FRESH™ GEL ALCOHOL HAND SANITIZER
GENTLE FRESH™ MANGO FOAMING HAND SOAP
GENTLE FRESH DEFENSE™